Match Document Document Title
US20130274138 GENE SIGNATURES FOR PREDICTION OF THERAPY-RELATED MYELODYSPLASIA AND METHODS FOR IDENTIFICATION OF PATIENTS AT RISK FOR DEVELOPMENT OF THE SAME  
In one embodiment, a gene expression signature for predicting risk of developing therapy-related myelodysplasia or acute myeloid leukemia (t-MDS/AML) after autologous hematopoietic cell...
US20130244901 METHOD AND SYSTEM FOR PROGNOSIS AND TREATMENT OF DISEASES USING PORTFOLIO OF GENES  
This disclosure generally relates to a method, a system and a kit for diagnosing and treating various disease conditions using the gene expression value in a given sample obtained from a subject....
US20130059755 Gene Based Prediction of PSA Recurrence for Clinically Localized Prostate Cancer Patients  
Disclosed are methods, devices and kits for determining the likelihood of recurrence of prostate cancer using the expression levels of preferably three-gene classifier. The methods, devices and...
US20110287954 PRIMERS, METHOD AND SET OF TOOLS FOR DETERMINING THE FUNCTIONALITY OF THE HUMAN THYMUS  
Determining thymic function in adults has attracted increasing interest in the context of diseases that affect the immunological system and, in particular, diseases that produce lymphopenias. The...
US20150240309 Methods and Tools for Vel Blood Group Typing  
The present invention relates to methods and tools for discriminating between Vel negative and Vel positive phenotypes. The invention is thus useful for determining Vel blood group status of...
US20120172243 SYSTEMS AND METHODS FOR EXPRESSION-BASED CLASSIFICATION OF THYROID TISSUE  
A system for classifying thyroid nodule tissue as malignant or benign is provided that is based on the identification of sets of gene transcripts, which are characterized in that changes in...
US20150232927 EVAULATION OF DUF1220 COPY NUMBER AND METHODS OF USING THE SAME  
Methods of selecting individuals having or predicted to develop abnormalities in brain volume, that may include microcephaly, or macrocephaly, and may manifest in neurological disorders such as...
US20140194305 INTEGRATED MULTIPLEX TARGET ANALYSIS  
This invention provides biochip cartridges and instrument devices for the detection and/or analysis of target analytes from patient samples.
US20140287949 MULTIPLEX ASSAY FOR MEMBERS OF BINDING PAIRS  
The invention provides an efficient multiplex method for identifying binding partners of small molecules and proteins. The small molecules and proteins are tagged with a nucleic acid barcode that...
US20130090382 METHODS, ASSAYS, AND KITS RELATED TO DICHLOROACETATE (DCA)  
Embodiments of the present disclosure provide for methods, assays, and kits for predicting dosing for subjects. In addition, embodiments of the present disclosure include methods, assays, and...
US20120210458 Isolated Novel Nucleic Acid and Protein Molecules from Corn and Methods of Using Thereof  
This disclosure provides purified nucleic acids and polypeptides and various uses of these sequences such as transcript profiling. Also provided are transgenic plants, seeds, and plant cells...
US20120023611 Isolated Novel Nucleic Acid and Protein Molecules from Corn and Methods of Using Thereof  
This disclosure provides purified nucleic acids and polypeptides and various uses of these sequences such as transcript profiling. Also provided are transgenic plants, seeds, and plant cells...
US20140329714 STAT3 ACTIVATION AS A MARKER FOR CLASSIFICATION AND PROGNOSIS OF DLBCL PATIENTS  
Methods are disclosed for determining classification and prognosis of patients with diffuse large B-cell lymphoma (DLBCL) using activation of signal transducer and activator of transcription 3...
US20140106981 Organ-Specific Proteins and Methods of Their Use  
The present invention relates generally to methods for identifying and using organ-specific proteins and transcripts. The present invention further provides compositions comprising organ-specific...
US20120087862 ORGAN-SPECIFIC PROTEINS AND METHODS OF THEIR USE  
The present invention relates generally to methods for identifying and using organ-specific proteins and transcripts. The present invention further provides compositions comprising organ-specific...
US20110070268 Method  
Methods for characterisation of patients as responders or non-responders to therapy based on differential expression of one or more genes are provided. Gene expression profiles, microarrays...
US20130023432 METHOD FOR PREDICTING THERAPEUTIC EFFECT OF IMMUNOTHERAPY ON CANCER PATIENT AND/OR PROGNOSIS AFTER IMMUNOTHERAPY, AND GENE SET AND KIT TO BE USED THERIN  
The present invention provides a method for predicting effect of immunotherapy on a cancer patient and/or prognosis of the cancer patient after the immunotherapy, and a gene set and a kit for use...
US20110014191 BREAST CANCER EXPRESSION PROFILING  
The present invention relates to a method for analyzing cancer. e.g., breast cancer including detection of differential expression of at least one of the 16 genes encoding serine/threonine kinases...
US20120197540 MARKERS TO PREDICT SURVIVAL OF BREAST CANCER PATIENTS AND USES THEREOF  
The present invention relates to a method to predict the mortality risk of a subject (p) affected of breast cancer comprising measuring the expression level of 105 specific genes in a biological...
US20110236314 METHOD OF DETECTION AND DIAGNOSIS OF ORAL AND NASOPHARYNGEAL CANCERS  
The present invention relates to cancer and in particular to oral and nasopharyngeal cancers. In particular, the present invention relates to a method of detection and diagnosis of oral squamous...
US20130116145 DIAGNOSIS AND PROGNOSIS OF BREAST CANCER PATIENTS  
The present invention relates to genetic markers whose expression is correlated with breast cancer. Specifically, the invention provides sets of markers whose expression patterns can be used to...
US20110301048 DIAGNOSIS AND PROGNOSIS OF BREAST CANCER PATIENTS  
The present invention relates to genetic markers whose expression is correlated with breast cancer. Specifically, the invention provides sets of markers whose expression patterns can be used to...
US20150152503 MICRORNAS FOR PREDICTION OF TREATMENT EFFICACY AND PROGNOSIS OF CANCER PATIENTS  
The present invention lies within the field of personalised medicine. More particular the invention relates to biomarkers useful for predicting treatment efficacy and prognosis in cancer patients....
US20110086349 Proliferation Signatures and Prognosis for Gastrointestinal Cancer  
This invention relates to methods and compositions for determining the prognosis of cancer in a patient, particularly for gastrointestinal cancer, such as gastric or colorectal cancer....
US20140066323 CANCER DIAGNOSTICS USING BIOMARKERS  
Disclosed herein, in certain instances, are methods, systems and kits for the diagnosis, prognosis and determination of cancer progression of a cancer in a subject. Further disclosed herein, in...
US20140274778 METHODS AND SYSTEMS FOR MULTIPLEX ASSAYS  
Disclosed herein are compositions comprising beads with unique identifiers for storing information about a multiplex assay as well as methods for using the same in multiplex chemical and...
US20150211053 BIOMARKERS FOR DIABETES AND USAGES THEREOF  
Biomarkers for diabetes and usages thereof are provided. And the biomarkers are Akkermansia muciniphila, Bacteroides intestinalis, Bacteroides sp. 20_3, Clostridium bolteae, Clostridium hathewayi,...
US20140228241 METHOD FOR PREDICTING THE RESPONSE TO CHEMOTHERAPY IN A PATIENT SUFFERING FROM OR AT RISK OF DEVELOPING RECURRENTBREAST CANCER  
A method for predicting a response to and/or benefit of chemotherapy, including neoadjuvant chemotherapy, in a patient suffering from or at risk of developing recurrent neoplastic disease, in...
US20130296193 METHOD FOR DISCOVERING A BIOMARKER  
The invention relates to a method for discovering biomarkers, comprising: matching the expression levels of genetic factors in persons, including a plurality of patients having a specific disease,...
US20110136683 Systems and Methods for Expression-Based Discrimination of Distinct Clinical Disease States in Prostate Cancer  
A system for expression-based discrimination of distinct clinical disease states in prostate cancer is provided that is based on the identification of sets of gene transcripts, which are...
US20150203912 PROTEIN DETECTION USING FET  
Accordingly, in some embodiments methods for detecting an analyte or analytes in one or more sample(s) are provided. The methods encompass providing a solid support with an addressable marker and...
US20120208718 SCHIZOPHRENIA TREATMENT RESPONSE BIOMARKERS  
The present invention provides biomarker of antipsychotic treatment response in patients with schizophrenia and other disorders involving DRD2 and methods for using the same.
US20150038359 METHOD OF PREDICTING OUTCOME IN CANCER PATIENTS  
A method of prognosis for a mammal with cancer is provided. The method includes the steps of determining in a biological sample obtained from the mammal the expression level of each biomarker of...
US20140141996 Methods and Compositions for the Treatment and Diagnosis of Cancer  
Embodiments of the disclosure are directed to methods of diagnosis, prognosis and treatment of cancer. In some embodiments, the methods include targeting a marker that is expressed at abnormal...
US20130184167 GENETIC MARKERS FOR THE PROGNOSIS OF MULTIPLE SCLEROSIS  
The present invention relates to a series of genes the expression of which is altered in subjects suffering multiple sclerosis with respect to healthy subjects or in subjects suffering multiple...
US20120115743 COMPOSITIONS AND METHODS FOR CLASSIFYING THYROID NODULE DISEASE  
A system for classifying thyroid nodule tissue as malignant or benign is provided that is based on the identification of sets of gene transcripts, which are characterized in that changes in...
US20130065791 METHODS AND KITS FOR DIAGNOSING COLORECTAL CANCER  
The invention pertains to a method for early detection and screening of colorectal cancer in human subjects based on RNA isolated from blood obtained from said subject. According to the invention,...
US20120225789 DNA REPAIR OR BRCA1-LIKE GENE SIGNATURE  
The present invention concerns the identification of individuals that have triple negative breast cancer and/or identification of an appropriate treatment therefor. In certain cases, the...
US20110287957 METHODS AND KITS FOR DIAGNOSING COLORECTAL CANCER  
The invention pertains to a method for early detection and screening of colorectal cancer in human subjects based on RNA isolated from blood obtained from said subject. According to the invention,...
US20150045238 BIOMARKERS FOR DIABETES  
The present invention provides a method for assessing the presence and risk of developing type 2 diabetes, cancer of all sites, or cardiovascular disease in a subject by detecting sequence...
US20120238464 Biomarkers for Predicting the Recurrence of Colorectal Cancer Metastasis  
The present invention includes biomarkers and methods for predicting recurrence-free survival and determination of risk for colorectal liver metastasis (LM) by determining a level of...
US20100304994 Oligonucleotide Paints  
Novel methods for making high resolution oligonucleotide paints are provided. Novel, high resolution oligonucleotide paints are also provided.
US20130225428 LIVER DISEASE MARKERS  
New markers for diseased liver conditions have been identified. A combination of protein C (PROC) and retinol binding protein 4 (RBP4) in blood are biomarkers to distinguish patients at different...
US20150197801 DNA BARCODING OF DESIGNER MONONUCLEOSOME AND CHROMATIN ARRAY LIBRARIES FOR THE PROFILING OF CHROMATIN READERS, WRITERS, ERASERS, AND MODULATORS THEREOF  
Compositions and methods are provided for DNA barcoding of designer mononucleosome and polynucleosome (chromatin array) libraries for use, for example, for the profiling of chromatin readers,...
US20140018252 GENE ARRAY TECHNIQUE FOR PREDICTING RESPONSE IN INFLAMMATORY BOWEL DISEASES  
Disclosed are methods for classifying individuals having or suspected of having an inflammatory bowel disease, such as Crohn's Disease or Ulcerative Colitis, as ‘responders’ or ‘non-responders’ to...
US20140106986 METHODS AND DEVICES FOR PROGNOSIS OF CANCER RELAPSE  
The present invention features microRNAs as biomarkers for prognosing cancer relapse in cancer patient. The present invention also features methods, devices, and kits for this purpose.
US20140018253 GENE EXPRESSION PANEL FOR BREAST CANCER PROGNOSIS  
The invention described in the application relates to a panel of gene expression markers for node-negative, ER-positive, HER2-negative breast cancer patients. The invention thus provides methods...
US20140200160 MOLECULAR-BASED METHOD OF CANCER DIAGNOSIS AND PROGNOSIS  
A gene profiling signature for diagnosis and prognosis of cancer patients is disclosed herein. In one embodiment, the gene signature includes 32 or 79 cancer survival factor-associated genes....
US20140256584 DIAGNOSIS OF MELANOMA AND SOLAR LENTIGO BY NUCLEIC ACID ANALYSIS  
The present invention provides methods for diagnosing melanoma and/or solar lentigo in a subject by analyzing nucleic acid molecules obtained from the subject. The present invention also provides...
US20120184447 Methods and Nucleic Acids for Analysis of Bladder Cell Proliferative Disorders  
The invention provides methods, nucleic acids and kits for detecting bladder carcinoma. The invention discloses genomic sequences the methylation patterns of which have utility for the improved...